C
N
S

#236 Billionaire

Andreas Struengmann & family

Andreas Struengmann & family
$11.5B
$-150M (-1.3%)
DE · Age 76
Source of wealth: Pharmaceuticals
Industry: healthcare
Residence: Tegernsee, DE
{ "bio": [ "Andreas Struengmann and twin brother Thomas were early backers of BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.", "The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.", "The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.", "In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann." ], "about": [ "After studying medicine in Freiburg, Germany, Andreas worked as a doctor in South Africa." ] }

Add a comment

Want to leave a comment?

Log in

Comments (0)

No comments yet. Be the first!